Home
About
Overview
Sharing Data
ORCID
Help
History (42)
Nuclear EGFR protein expression predicts poor survival in early stage non-small cell lung cancer.
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study.
Phase II study of the multitargeted tyrosine kinase inhibitor XL647 in patients with non-small-cell lung cancer.
Arber, Daniel
Maintenance or consolidation therapy in small-cell lung cancer: a systematic review and meta-analysis.
See All 42 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Maintenance or consolidation therapy in small-cell lung cancer: a systematic review and meta-analysis.
Maintenance or consolidation therapy in small-cell lung cancer: a systematic review and meta-analysis. Lung Cancer. 2010 Nov; 70(2):119-28.
View in:
PubMed
subject areas
Carcinoma, Small Cell
Disease-Free Survival
Humans
Immunotherapy
Interferons
Lung Neoplasms
Randomized Controlled Trials as Topic
authors with profiles
Marina Chiara Garassino